Supporting Multiple Global Gene Therapy Studies For Rare Diseases
Supporting Multiple Global Gene Therapy Studies For Rare Diseases A long-term client called upon the Veristat team for help conducting two investigational Phase I/II studies. These global studies focused on proving the safety and efficacy of gene therapy for two rare genetic disorders. Working side-by-side with the client, our cell and gene therapy experts addressed many complicated challenges – including site start-up issues, stringent regulatory requirements, and the logistics of handling highly sensitive genetic material. Study Demographics Primary Services Provided: Signing up provides ...